Pharma considers alternatives to large sales forces
27 Feb 2024
When Courtney Ness worked as a sales rep for Forest Pharmaceuticals in the early 2000s, she sold the antidepressant Lexapro as part of a 3,000-person sales force.
Her top priority was Lexapro, and she and her teammate called on the same set of doctors.
During a typical month, Ness would talk to a doctor about Lexapro one week, and her teammate would do the same two weeks later. A set of “secondary” sales reps covered the remaining weeks. If all four reps got in, every accessible doctor on the list heard a Lexapro message once a week.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.